Risk-adapted adjuvant chemotherapy after concomitant fluoropyrimidine- radiotherapy neoadjuvant treatment for patients with resectable cT3-4 or N+ rectal cancer

1. Sastre, J.
2. Custodio, A.
3. Sanchez, J.C.
4. Ortega, L.
5. Rodriguez, L.
6. Puente, J.
7. Corona, J.
8. Alfonso, R.
9. De Las Heras, M.
10. Díaz-Rubio, E.